Stocks
Gilead Sciences (GILD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 775.2% | 926.3% | 683.7% | 977.8% | 1 349% | ||||
| Changes by years, y/y, % | -329pp | +151pp | -926pp | +294pp | +12.5% | ||||
Gilead Sciences. R&D/CAPEX, %
Gilead Sciences. R&D/CAPEX, changes, pp
Gilead Sciences (GILD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 1 194% | 675.3% | 1 337% | 1 400% | 1 349% | |||
| Changes by years, y/y, % | +462pp | -855pp | -180pp | +10pp | +72pp | |||
| Changes by quarters, q/q, % | +182pp | -1 194pp | +662pp | +63pp | ||||
